Inhibitors of Bacillus subtilis DNA polymerase III. Structure-activity relationships of 6-(phenylhydrazino)uracils
- PMID: 411933
- DOI: 10.1021/jm00219a014
Inhibitors of Bacillus subtilis DNA polymerase III. Structure-activity relationships of 6-(phenylhydrazino)uracils
Abstract
6-(Phenylhydrazino)uracils inhibit the replication-specific enzyme DNA polymerase III of Bacillus subtilis by forming a strong, reversible complex with template-primer DNA and enzyme. The phenyl ring interacts with a hydrophobic enzyme site which, on the basis of structure-activity relationships of substituted analogues, appears to possess the following characteristics: (1) planarity or near-planarity; (2) a finite capacity to accommodate bulky substituents; and (3) location near the domain of the enzyme active site. A mutant DNA polymerase III, derived from a mutant strain of B. subtilis selected for resistance to 6-(p-hydroxyphenylazo)pyrimidines, is resistant only to inhibitors bearing p-hydroxy or amino groups and is hypersensitive to inhibitors containing nonpolar substituents; these results suggest the existence of mutable, secondary regions of the binding site which interact with para substituents and, thus, influence the strength of the primary phenyl-enzyme interaction.
Similar articles
-
Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.J Med Chem. 1980 Jan;23(1):34-8. doi: 10.1021/jm00175a007. J Med Chem. 1980. PMID: 6767030
-
Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracils.J Med Chem. 1977 Sep;20(9):1186-9. doi: 10.1021/jm00219a015. J Med Chem. 1977. PMID: 411934
-
Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III.J Med Chem. 1984 Feb;27(2):181-5. doi: 10.1021/jm00368a013. J Med Chem. 1984. PMID: 6420570
-
The mechanism of action of inhibitors of DNA synthesis.Annu Rev Biochem. 1977;46:641-68. doi: 10.1146/annurev.bi.46.070177.003233. Annu Rev Biochem. 1977. PMID: 143235 Review. No abstract available.
-
Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections.Bioorg Med Chem. 2019 Aug 1;27(15):3209-3217. doi: 10.1016/j.bmc.2019.06.017. Epub 2019 Jun 11. Bioorg Med Chem. 2019. PMID: 31221610 Review.
Cited by
-
Dynamic Exchange of Two Essential DNA Polymerases during Replication and after Fork Arrest.Biophys J. 2019 Feb 19;116(4):684-693. doi: 10.1016/j.bpj.2019.01.008. Epub 2019 Jan 11. Biophys J. 2019. PMID: 30686488 Free PMC article.